Related Experiment Video
Updated: Oct 24, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Factors determining the treatment ineffectiveness in multiple sclerosis
1Department of Neurology, Trakya University Faculty of Medicine, Edirne, Turkey.
Evaluating suboptimal responses in multiple sclerosis (MS) treatment is crucial for long-term effectiveness. Early, individualized treatment based on disease severity can prevent disability and improve outcomes.
Area of Science:
- Neurology
- Immunology
Background:
- Suboptimal treatment response in multiple sclerosis (MS) requires careful evaluation at all stages.
- Timely intervention is critical, especially in early disease stages, to achieve long-term treatment effectiveness.
Purpose of the Study:
- To emphasize the importance of evaluating suboptimal responses in multiple sclerosis (MS) treatment.
- To highlight the critical window for intervention in early MS stages for long-term benefits.
Main Methods:
- Clinical variables assessment
- MRI activity monitoring
- Patient and physician perception evaluation
- Adverse event and risk assessment
Main Results:
- Identifying patients with moderate to high disease activity and suboptimal response is key.
- Early and individualized MS treatment, tailored to disease severity, can prevent medium/long-term radiological and physical disability.
Conclusions:
- The evolving landscape of MS treatments necessitates a shift in patient-physician interactions.
- Shared decision-making, considering individual patient factors, benefits, and risks, is essential for optimal MS management.
More Related Videos
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Factors Affecting Drug Response: Overview
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Therapy
Antianxiety Medications
Alzheimer's Disease: Treatment

